Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor

被引:0
|
作者
Jolanta Grzenkowicz-Wydra
Jarosław Cisowski
Joanna Nakonieczna
Adrian Zarębski
Natalia Udilova
Hans Nohl
Alicja Józkowicz
Anna Podhajska
Józef Dulak
机构
[1] Jagiellonian University,Department of Cell Biochemistry, Faculty of Biotechnology
[2] University of Gdańsk,Department of Biotechnology, Intercollegiate Faculty of Biotechnology
[3] Veterinary University of Vienna,Basic Pharmacology and Toxicology
[4] Jagiellonian University,Department of Molecular Genetics, Faculty of Biotechnology
[5] University of Vienna,Department of Vascular Surgery
来源
Molecular and Cellular Biochemistry | 2004年 / 264卷
关键词
angiogenesis; nitric oxide; heme oxygenase-1; reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
Nitric oxide (NO) and reactive oxygen species (ROS) are emerging as important regulators of angiogenesis. NO enhances VEGF synthesis in several cell types and is required for execution of VEGF angiogenic effect in endothelial cells. Similarly, hydrogen peroxide induces VEGF synthesis and recent studies indicate the involvement of ROS in signaling downstream of VEGF stimulation. VEGF synthesis can not only be enhanced by gene transfer of VEGF but also by overexpression of NO synthase genes. Here, we examined the possibility of augmentation of VEGF production by gene transfer of copper/zinc superoxide dismutase (CuZnSOD, SOD1). Overexpression of human SOD1 in mouse NIH 3T3 fibroblasts increased SOD activity, enhanced intracellular generation of H2O2 and significantly stimulated VEGF production as determined by increase in VEGF promoter activity, VEGF mRNA expression and VEGF protein synthesis. The stimulatory effect on VEGF synthesis induced by SOD1 gene transfer was reverted by overexpression of human catalase. The effect of H2O2 produced by engineered cells is mediated by activation of hypoxia-inducible factor response element (HRE) as well as Sp1 recognition site of VEGF promoter. This data suggest the feasibility of stimulation of angiogenesis by overexpression of SOD1. (Mol Cell Biochem 264: 169–181, 2004)
引用
收藏
页码:169 / 181
页数:12
相关论文
共 50 条
  • [41] Vascular Endothelial Growth Factor Gene Polymorphisms in Spontaneously Aborted Fetuses
    Jeon, Young Joo
    Kim, Ji Hyang
    Rah, HyungChul
    Kim, Su Yeoun
    Yoon, Tae Ki
    Choi, Dong Hee
    Cha, Sun Hee
    Shim, Sung Han
    Kim, Nam Keun
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (06) : 544 - 553
  • [42] Targeting vascular endothelial growth factor using retinal gene therapy
    Chung, Sook H.
    Frick, Sonia L.
    Yiu, Glenn
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (15)
  • [43] Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival
    Lose, Felicity
    Nagle, Christina M.
    O'Mara, Tracy
    Batra, Jyotsna
    Bolton, Kelly L.
    Song, Honglin
    Ramus, Susan J.
    Gentry-Maharaj, Aleksandra
    Menon, Usha
    Gayther, Simon A.
    Pharoah, Paul D. P.
    Kedda, Mary-Anne
    Spurdle, Amanda B.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 479 - 483
  • [44] Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats
    Takeshita, S
    Isshiki, T
    Mori, H
    Tanaka, E
    Tanaka, A
    Umetani, K
    Eto, K
    Miyazawa, Y
    Ochiai, M
    Sato, T
    CARDIOVASCULAR RESEARCH, 1997, 35 (03) : 547 - 552
  • [45] Adenoviral Gene Transfer of Gremlin Modulates Vascular Endothelial Growth Factor-A-Induced Angiogenesis in Porcine Myocardium
    Pajula, Juho J.
    Halonen, Paavo J.
    Hatinen, Olli-Pekka
    Yla-Herttuala, Seppo
    Nurro, Jussi
    HUMAN GENE THERAPY, 2020, 31 (3-4) : 211 - 218
  • [46] Angiogenic gene therapy with vascular endothelial growth factor — Hope or hype?Angiogenetische Gentherapie mit „Vascular Endothelial Growth Factor“ — Hoffnung oder Illusion?
    J. Dulak
    Alicja Jozkowicz
    European Surgery, 2002, 34 (2) : 101 - 104
  • [47] Adeno-associated virus-mediated vascular endothelial growth factor gene transfer into cardiac myocytes
    Maeda, Y
    Ikeda, U
    Shimpo, M
    Shibuya, M
    Monahan, J
    Urabe, M
    Ozawa, K
    Shimada, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) : 438 - 443
  • [48] Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors
    Kang, Byung Woog
    Kim, Jong Gwang
    Chae, Yee Soo
    Bae, Han Ik
    Kwon, Ohkyoung
    Chung, Ho Young
    Yu, Wansik
    Song, Hong Suk
    Kang, Yu Na
    Ryu, Seung Wan
    Lee, Kyung Hee
    Bae, Young Kyung
    Choi, Joon Hyuk
    Kim, Se Won
    Ryoo, Hun-Mo
    Cho, Chang-Ho
    Chae, Hyun-Dong
    Park, Kyun Woo
    Gu, Mi Jin
    Bae, Byung-Jo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (02) : E40 - E45
  • [49] LDL Coating pVEGF/polyethylenimine Complex Enhances Vascular Endothelial Growth Factor Expression
    Li, Jian
    Yang, Guang
    Feng, Min
    Liang, Hailong
    Zhang, Jun
    Huang, Danhong
    Deng, Siyun
    Shen, Yuan
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2012, 17 (06) : 1182 - 1189
  • [50] Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps
    Yi, Chenggang
    Xia, Wei
    Zheng, Yan
    Zhang, Lingxi
    Shu, Maoguo
    Liang, Jie
    Han, Yan
    Guo, Shuzhong
    JOURNAL OF SURGICAL RESEARCH, 2006, 135 (01) : 100 - 106